Precision Cancer Trials Are Booming Despite Skeptics Who Doubt Their Value

Cancer trials that match patients to treatments based on genetic factors are on the rise. But will they improve patient outcomes?

from Forbes – Tech http://ift.tt/2huKQ3g
via IFTTT